The Ostrova Charitable Foundation has published the Russian translation of US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.
Non-tuberculous mycobacteria are very common in the environment and might cause chronic lung infection, especially in individuals with cystic fibrosis. Pulmonary involvement caused by such bacteria can pose a serious threat for CF patients. Yet there are no standardised diagnostics and treatment procedures for mycobacteriosis so far. In 2016, the US Cystic Fibrosis Foundation and European Cystic Fibrosis Society issued consensus recommendations for screening, testing, diagnosing and treating mycobacteriosis in CF patients. According to the authors, the recommendations would help improve treatment of such patients.
The translation was made possible by the Future Actually Registered Charity and edited by Prof. N. Kashirskaya (PhD), senior associate at the Laboratory for Genetic Epidemiology of the Academic Genetic Centre. A. Lyamin (PhD, associate professor at the Department of Mircobiology, Immunology and Allergology at Samara State Medical University, clinical bacteriologist at the Microbiology Department of the Clinical Diagnostic Laboratory of Samara State Medical University) acted as advisor.